Video

Educated Patient® Lung Cancer Summit Looking Ahead Session: August 14, 2021

Author(s):

CURE Media Group

View the full CURE Educated Patient Lung Cancer Summit on demand.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Stay up to date on cancer updates, research and education

      Subscribe Now!
      Related Videos
      Image of Dr. Boffa.
      How Cancer Care Teams Can Help With the Cessation of Smoking
      Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
      Smoking Data May Guide Improved Lung Cancer Care and Patient Support
      Image of Dr. Reznick
      How to Best Navigate a Diagnosis of Lung and Head and Neck Cancer
      There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
      The Benefit of Clinical Trial Enrollment for Patients With Cancer
      Image of smiling doctor.
      Top 3 Takeaways From ASCO GU 2025
      Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
      Emphasizing the Importance of Breast Cancer Education and Screenings
      Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
      The Power of Knowledge and Staying Informed in Breast Cancer Care
      Discussing the Mission of CURE With Our Former and New Editors-In-Chief
      Discussing the Mission of CURE With Our Former and New Editors-In-Chief
      Image of woman with blonde hair.
      Targeted Axillary Dissection Offers a Precise Option in Breast Cancer
      Image of woman with blonde hair.
      Guiding Patients Through Shared Decision-Making in Breast Cancer Care
      Related Content
      Illustration of lungs.
      May 15th 2025

      Ventana MET RxDx Assay Receives FDA Approval as Companion Diagnostic in NSCLC

      Ryan Scott
      The FDA approved the Ventana MET RxDx assay, making it the first companion diagnostic to aid in determining MET protein expression in non-squamous NSCLC.
      CURE Cancer Horizons logo
      February 26th 2024

      FDA Approvals from February 2024

      Alex Biese Brielle Benyon
      February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
      "FDA" text
      May 14th 2025

      FDA Approves Emrelis in Previously Treated, Advanced NSCLC

      Ryan Scott
      The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met protein overexpression.
      Guidelines for Childhood Neuroblastoma, FDA Decisions and More
      February 12th 2024

      Guidelines for Childhood Neuroblastoma, FDA Decisions and More

      Alex Biese Brielle Benyon
      Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
      Investigators are using MET immunohistochemistry testing to address unmet needs in NSCLC treatment: © stock.adobe.com.
      May 12th 2025

      IHC Testing Aims to Expand Personalized Treatment in Lung Cancer

      Ryan Scott
      Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address unmet needs in NSCLC treatment.
      Mary Anderson, B.S.N., RN, OCN
      May 11th 2025

      A Lifelong Advocate and Innovator

      Kristen Detweiler Short, FNP-BC
      Mary Anderson, B.S.N., RN, OCN, embodies the spirit of an Extraordinary Healer.